Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Raloxifene Glucuronidation in Human Intestine, Kidney, and Liver Microsomes and in Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism

Tina Trdan Lušin, Jurij Trontelj and Aleš Mrhar
Drug Metabolism and Disposition December 2011, 39 (12) 2347-2354; DOI: https://doi.org/10.1124/dmd.111.041897
Tina Trdan Lušin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jurij Trontelj
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleš Mrhar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 39 no. 12 2347-2354
DOI 
https://doi.org/10.1124/dmd.111.041897
PubMed 
21937736

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 22, 2011
  • Accepted September 21, 2011
  • Published online November 21, 2011.

Article Versions

  • Earlier version (September 21, 2011 - 10:13).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Tina Trdan Lušin,
  2. Jurij Trontelj and
  3. Aleš Mrhar
  1. Department of Biopharmacy and Pharmacokinetics, University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
  1. Address correspondence to:
    Tina Trdan Lušin, Aškerčeva 7, 1000 Ljubljana, Slovenia. E-mail: tina.trdan{at}ffa.uni-lj.si
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2011 to January 2021

AbstractFullPdf
Sep 2011249060
Oct 2011109079
Nov 2011245367
Dec 2011244627
Jan 20121351435
Feb 20121241123
Mar 2012116922
Apr 201255712
May 20125266
Jun 20124324
Jul 20122856
Aug 20124328
Sep 201228116
Oct 20123536
Nov 201247813
Dec 2012441215
Jan 2013482926
Feb 2013482320
Mar 2013291622
Apr 2013462521
May 2013512943
Jun 20131679
Jul 2013241411
Aug 20131298
Sep 2013441213
Oct 201335137
Nov 20132041
Dec 2013423
Jan 20141165
Feb 20141648
Mar 20143278
Apr 201417124
May 2014141414
Jun 201426511
Jul 2014151711
Aug 20141574
Sep 2014191413
Oct 20143779
Nov 201414610
Dec 20142087
Jan 20152798
Feb 20156711
Mar 201523187
Apr 201513128
May 2015151413
Jun 20151682
Jul 2015141018
Aug 201514108
Sep 2015101513
Oct 20151064
Nov 20154321
Dec 20151244
Jan 201611310
Feb 2016777
Mar 20161778
Apr 20161973
May 201611113
Jun 2016943
Jul 2016985
Aug 20162055
Sep 2016583
Oct 20161382
Nov 201643410
Dec 2016396
Jan 2017073
Feb 201721311
Mar 20171202
Apr 2017063
May 201751613
Jun 20171144
Jul 2017073
Aug 201762011
Sep 201721411
Oct 201711812
Nov 201701616
Dec 2017132414
Jan 201812685
Feb 2018314017
Mar 2018213215
Apr 201805816
May 201815716
Jun 201803817
Jul 201813415
Aug 20181147
Sep 20180126
Oct 201804315
Nov 201856412
Dec 201840911
Jan 20193814
Feb 20194029
Mar 20192949
Apr 20192126
May 20191556
Jun 20191115
Jul 20191215
Aug 20191007
Sep 20192433
Oct 20192051
Nov 20192242
Dec 20192735
Jan 20202802
Feb 2020932
Mar 20202604
Apr 20201136
May 2020800
Jun 20201042
Jul 2020954
Aug 2020703
Sep 2020600
Oct 20201702
Nov 20201501
Dec 2020414
Jan 20211022

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 39 (12)
Drug Metabolism and Disposition
Vol. 39, Issue 12
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Raloxifene Glucuronidation in Human Intestine, Kidney, and Liver Microsomes and in Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

UGT1A1*28 GENOTYPE INFLUENCE ON RALOXIFENE METABOLISM

Tina Trdan Lušin, Jurij Trontelj and Aleš Mrhar
Drug Metabolism and Disposition December 1, 2011, 39 (12) 2347-2354; DOI: https://doi.org/10.1124/dmd.111.041897

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

UGT1A1*28 GENOTYPE INFLUENCE ON RALOXIFENE METABOLISM

Tina Trdan Lušin, Jurij Trontelj and Aleš Mrhar
Drug Metabolism and Disposition December 1, 2011, 39 (12) 2347-2354; DOI: https://doi.org/10.1124/dmd.111.041897
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics